1. Home
  2. VCEL vs PTON Comparison

VCEL vs PTON Comparison

Compare VCEL & PTON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCEL
  • PTON
  • Stock Information
  • Founded
  • VCEL 1989
  • PTON 2012
  • Country
  • VCEL United States
  • PTON United States
  • Employees
  • VCEL N/A
  • PTON N/A
  • Industry
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • PTON Recreational Games/Products/Toys
  • Sector
  • VCEL Health Care
  • PTON Consumer Discretionary
  • Exchange
  • VCEL Nasdaq
  • PTON Nasdaq
  • Market Cap
  • VCEL 2.1B
  • PTON 2.5B
  • IPO Year
  • VCEL 1997
  • PTON 2019
  • Fundamental
  • Price
  • VCEL $41.83
  • PTON $6.58
  • Analyst Decision
  • VCEL Strong Buy
  • PTON Buy
  • Analyst Count
  • VCEL 8
  • PTON 19
  • Target Price
  • VCEL $62.00
  • PTON $7.78
  • AVG Volume (30 Days)
  • VCEL 430.3K
  • PTON 14.6M
  • Earning Date
  • VCEL 07-31-2025
  • PTON 08-21-2025
  • Dividend Yield
  • VCEL N/A
  • PTON N/A
  • EPS Growth
  • VCEL 521.85
  • PTON N/A
  • EPS
  • VCEL 0.05
  • PTON N/A
  • Revenue
  • VCEL $238,541,000.00
  • PTON $2,527,400,000.00
  • Revenue This Year
  • VCEL $23.03
  • PTON N/A
  • Revenue Next Year
  • VCEL $24.52
  • PTON N/A
  • P/E Ratio
  • VCEL $805.02
  • PTON N/A
  • Revenue Growth
  • VCEL 14.80
  • PTON N/A
  • 52 Week Low
  • VCEL $37.39
  • PTON $2.83
  • 52 Week High
  • VCEL $63.00
  • PTON $10.90
  • Technical
  • Relative Strength Index (RSI)
  • VCEL 47.28
  • PTON 48.69
  • Support Level
  • VCEL $40.53
  • PTON $6.36
  • Resistance Level
  • VCEL $43.57
  • PTON $7.04
  • Average True Range (ATR)
  • VCEL 1.67
  • PTON 0.38
  • MACD
  • VCEL -0.10
  • PTON -0.01
  • Stochastic Oscillator
  • VCEL 27.68
  • PTON 35.85

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

About PTON Peloton Interactive Inc.

Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product revenue consists of bike and tread and related accessories sales, associated fees for delivery and installation, and extended warranty agreements. Subscription revenue is generated from monthly Connected Fitness Subscription and Digital Subscription. The company generates maximum revenue from the Subscription segment. Geographically, the company derives a majority of its revenue from North America and the rest from the International markets.

Share on Social Networks: